Clinical Trials Logo

Filter by:
NCT ID: NCT05799326 Recruiting - Clinical trials for Acute Ischemic Stroke

Safety and Efficacy of Levofloxacin for Acute Ischemic Stroke

Start date: June 30, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the efficacy and safety of levofloxacin in treating acute ischemic stroke.

NCT ID: NCT05799287 Recruiting - IgA Nephropathy Clinical Trials

A Study of Telitacicept in Patients With Primary IgA Nephropathy

Start date: April 28, 2023
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of Telitacicept in patients with primary IgA nephropathy.

NCT ID: NCT05799183 Recruiting - Advanced Tumors Clinical Trials

A SHR-1210 BE Study on Healthy Subjects

Start date: July 4, 2023
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the bioequivalence of SHR-1210 before and after process changes.

NCT ID: NCT05799040 Recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

Evaluation of the Effectiveness of the Self-developed Pulmonary Lobar Ventilation Detector

Start date: October 26, 2023
Phase:
Study type: Observational

The goal of observational study is to Evaluation of the effectiveness of the self-developed pulmonary lobar ventilation detector in Chronic Obstructive Pulmonary Disease. The main question it aims to answer are:Evaluation of the effectiveness of the self-developed pulmonary lobar ventilation detector. Participants will use the self-developed pulmonary lobar ventilation detector and the imported Chartis detection system to evaluate the target pulmonary lobar collateral ventilation.

NCT ID: NCT05798845 Recruiting - NSCLC Clinical Trials

The Effect of Toripalimab Plus Radiotherapy in Patients With Operable Stage II-IIIA (N+) Non Small Cell Lung Cancer

Start date: February 20, 2023
Phase: Phase 2
Study type: Interventional

This randomized phase II trial is to explore the clinical efficacy, safety and feasibility of neoadjuvant immunotherapy plus radiotherapy compared with neoadjuvant immunotherapy plus chemotherapy in operable stage II-IIIA (N+) non small cell lung cancer (NSCLC) and the optimal radiotherapy pattern.

NCT ID: NCT05798793 Recruiting - Clinical trials for Oral Squamous Cell Carcinoma

Neoadjuvant Anti-PD-1 Immunotherapy With Chemotherapy in Resectable Locally Advanced Oral Squamous Cell Carcinoma

NEOPCOSCC
Start date: November 21, 2023
Phase: Phase 3
Study type: Interventional

The purpose of this study is to investigate the survival benefit of neoadjuvant anti-PD-1 immunotherapy plus TP chemotherapy compared with TP chemotherapy or up-front surgery in resectable locally advanced oral squamous cell carcinoma.

NCT ID: NCT05798546 Recruiting - Solid Tumor Clinical Trials

Treatment of Advanced Solid Tumors With Neo-T(GI-NeoT-02)

Start date: September 28, 2022
Phase: Phase 1
Study type: Interventional

The primary objective of this study is to evaluate the safety of Neo-T in the treatment of advanced solid tumors. The secondary objective of this study is to evaluate preliminarily the effect of Neo-T in the treatment of advanced solid tumors.

NCT ID: NCT05798533 Recruiting - Solid Tumor Clinical Trials

Neo-T in Treating Patients With Advanced Solid Tumors(GI-NeoT-03)

Start date: January 10, 2023
Phase: Phase 1
Study type: Interventional

The primary objective of this study is to evaluate the safety of Neo-T in combination with anti-PD1 in patients with solid tumors. The secondary objective of this study is to evaluate preliminarily the effect of Neo-T in combination with anti-PD1 in patients with solid tumors.

NCT ID: NCT05798403 Recruiting - Overactive Bladder Clinical Trials

Efficacy of Electroacupuncture Versus Solifenacin Succinate for Female Overactive Bladder

Start date: July 7, 2023
Phase: N/A
Study type: Interventional

Through a scientific and standardized multicenter, blinding, double-dummy, randomized controlled, noninferiority clinical trial study method, the investigators evaluated electroacupuncture as a safe and effective non-pharmacological treatment for OAB in women by comparison with Solifenacin Succinate.

NCT ID: NCT05798195 Recruiting - COVID-19 Pneumonia Clinical Trials

Traditional Chinese Medicine or Low-dose Dexamethasone in COVID-19 Pneumonia

Start date: January 1, 2023
Phase: N/A
Study type: Interventional

The goal of this type of clinical trial is to learn about symptomatic patients with post-COVID-19 parenchymal lung abnormalities. The main questions it aims to answer are: the efficacy and safety of low-dose dexamethasone or traditional Chinese medicine in symptomatic patients with post-COVID-19 parenchymal lung abnormalities. Participants will be divided into three parallel groups:controlled group with conventional western medicine treatment including oxygen therapy, antibiotics, nebulization therapy, etc. dexamethasone group: dexamethasone 1.5mg/day for one week and 0.75mg/day for another week basing on conventional western medicine. Chinese medicine group: Strengthening spleen and tonifying lung decoction for 2 weeks basing on conventional western medicine.